Need help finding what you are looking for?
Contact Us
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980184
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980184
Biomarkers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Growth Factors of biomarkers Market
The global biomarkers market was valued at USD 86.95 billion in 2025 and is projected to grow to USD 97.5 billion in 2026, reaching USD 217.58 billion by 2034, reflecting a robust CAGR of 12.2% during the forecast period. North America dominated the market in 2025, accounting for a 36.93% share, driven by strong adoption in personalized medicine, significant investments by key players, and advanced healthcare infrastructure.
Biomarkers, or biological markers, are measurable indicators of the biological state of an organ, tissue, or cell. They are critical in disease diagnosis, drug discovery, safety assessment, and biomedical research. Biomarkers are broadly classified based on function, including diagnostic, prognostic, predictive, and other biomarkers, and on biological properties such as genomics, proteomics, and metabolomics.
Market Drivers
The global biomarkers market is primarily driven by the growing diagnostic applications of biomarkers. Biomarkers play an essential role in personalized medicine, helping tailor treatment plans based on a patient's clinical and genetic profile. This is particularly valuable in oncology, where biomarker-guided therapies enhance treatment efficacy. The increasing prevalence of cancer, cardiovascular, and neurodegenerative diseases further fuels demand.
Technological advancements in disease diagnosis, rising investment in biomarker-based drug discovery, and adoption of companion diagnostics are key factors accelerating market growth. For example, Pfizer's Selzentry (Maraviroc) utilizes the Trofile assay biomarker to determine patient response to HIV treatment. Similarly, DiamiR received an award from the Alzheimer's Drug Discovery Foundation in 2019 for research on circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration.
Market Restraints
Challenges include high research and development costs, regulatory hurdles, and the need for specialized equipment for biomarker detection. Limited awareness in some emerging markets and the complexity of integrating biomarker data into clinical decision-making may also restrain growth.
Segmentation Analysis
By Indication:
- Oncology dominated the market in 2025 and is expected to hold the largest share in 2026 with 49.44%, driven by rising cancer prevalence and increased use of biomarker-based diagnostics for targeted therapies.
- Cardiology is growing due to the increasing use of biomarkers like troponin for diagnosing cardiovascular diseases.
- Neurology and other indications are emerging segments, fueled by biomarker research in neurodegenerative and rare diseases.
By End User:
- Diagnostics and research laboratories are the largest end-user segment, expected to hold 52.89% of the market in 2026, supported by extensive grants and investment in biomarker development.
- Pharmaceutical & biotechnology companies, hospitals, and specialty clinics represent other end-users driving adoption.
Regional Insights
North America:
- Market size: USD 32.12 billion in 2025, projected USD 35.87 billion in 2026.
- Growth is fueled by strong adoption in personalized medicine, extensive R&D investment, and favorable regulatory approvals. The U.S. market alone is projected to reach USD 31.17 billion in 2026.
Europe:
- Supported by the EU's regulatory framework for in-vitro diagnostics (IVDR), robust clinical research infrastructure, and collaborations between biotech companies and healthcare institutions. The UK market is projected at USD 4.62 billion and Germany at USD 8.02 billion by 2026.
Asia Pacific:
- Market growth is expected to be significant due to the increasing prevalence of cancer and cardiovascular diseases. The Japan market is projected at USD 7.34 billion, China at USD 6.66 billion, and India at USD 2.65 billion by 2026. Rising investments in biomarker-based drug discovery are boosting adoption.
Middle East, Africa, and Latin America:
- Emerging regions are witnessing growth due to the entry of global players, improved healthcare infrastructure, and increased focus on biomarker-based diagnostics.
Key Market Players
The biomarkers market is highly fragmented, led by F. Hoffmann-La Roche Ltd., Abbott, and Thermo Fisher Scientific, Inc., supported by strong R&D and innovation in diagnostic assays. Other notable players include Bio-Rad Laboratories, CENTOGENE N.V., Axon Medchem, Sino Biological Inc., R&D Systems, BioVision Inc., and Myriad RBM.
Recent Developments:
- January 2025: Launch of AI-engineered designer proteins for regenerative medicine.
- February 2025: Expansion of RNAscope(TM) probe portfolio for biomarker validation.
- November 2024: Achieved IVDR certification for R&D Systems hematology controls.
- May 2023: FDA clearance for B*R*A*H*M*S PlGF plus KRYPTOR immunoassays.
Conclusion
The biomarkers market is set for significant growth, from USD 86.95 billion in 2025 to USD 217.58 billion by 2034, fueled by the increasing adoption of personalized medicine, advancements in diagnostics, and the rising prevalence of chronic diseases. Strong investments in R&D, the introduction of novel biomarkers, and collaborations between biotech companies are expected to further drive market expansion across regions, particularly in North America and Asia Pacific.
Segmentation By Indication
- Oncology
- Cardiology
- Neurology
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- Diagnostics & Research Laboratories
- Hospitals & Specialty Clinics
- Others
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Product Code: FBI102173
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. New Product Launches, by Key Market Players
- 4.2. Prevalence by Disease Indication, By Key Countries/ Region, 2025
- 4.3. Incidence of Cancer, By Key Countries/ Key Region,2025
- 4.4. Key industry Developments - Mergers, Acquisitions and Partnerships
- 4.5. Overview of Biomarkers In Personalized Medicine
5. Global Biomarkers Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast - By Indication
- 5.2.1. Oncology
- 5.2.2. Cardiology
- 5.2.3. Neurology
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Pharmaceutical & Biotechnology Companies
- 5.3.2. Diagnostics & Research Laboratories
- 5.3.3. Hospitals & Specialty Clinics
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Biomarkers Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast - By Indication
- 6.2.1. Oncology
- 6.2.2. Cardiology
- 6.2.3. Neurology
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Pharmaceutical & Biotechnology Companies
- 6.3.2. Diagnostics & Research Laboratories
- 6.3.3. Hospitals & Specialty Clinics
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Biomarkers Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast - By Indication
- 7.2.1. Oncology
- 7.2.2. Cardiology
- 7.2.3. Neurology
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Pharmaceutical & Biotechnology Companies
- 7.3.2. Diagnostics & Research Laboratories
- 7.3.3. Hospitals & Specialty Clinics
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Biomarkers Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast - By Indication
- 8.2.1. Oncology
- 8.2.2. Cardiology
- 8.2.3. Neurology
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Pharmaceutical & Biotechnology Companies
- 8.3.2. Diagnostics & Research Laboratories
- 8.3.3. Hospitals & Specialty Clinics
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Biomarkers Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast - By Indication
- 9.2.1. Oncology
- 9.2.2. Cardiology
- 9.2.3. Neurology
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Pharmaceutical & Biotechnology Companies
- 9.3.2. Diagnostics & Research Laboratories
- 9.3.3. Hospitals & Specialty Clinics
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Biomarkers Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast - By Indication
- 10.2.1. Oncology
- 10.2.2. Cardiology
- 10.2.3. Neurology
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Pharmaceutical & Biotechnology Companies
- 10.3.2. Diagnostics & Research Laboratories
- 10.3.3. Hospitals and Specialty Clinics
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. GCC Countries
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2025)
- 11.3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.3.1. F. Hoffmann-La Roche Ltd.
- 11.3.1.1. Overview,
- 11.3.1.2. Products & services,
- 11.3.1.3. SWOT analysis,
- 11.3.1.4. Recent developments,
- 11.3.1.5. strategies,
- 11.3.1.6. financials (based on availability)
- 11.3.2. Abbott
- 11.3.2.1. Overview,
- 11.3.2.2. Products & services,
- 11.3.2.3. SWOT analysis,
- 11.3.2.4. Recent developments,
- 11.3.2.5. strategies,
- 11.3.2.6. financials (based on availability)
- 11.3.3. Thermo Fisher Scientific
- 11.3.3.1. Overview,
- 11.3.3.2. Products & services,
- 11.3.3.3. SWOT analysis,
- 11.3.3.4. Recent developments,
- 11.3.3.5. strategies,
- 11.3.3.6. financials (based on availability)
- 11.3.4. Bio-Rad Laboratories, Inc
- 11.3.4.1. Overview,
- 11.3.4.2. Products & services,
- 11.3.4.3. SWOT analysis,
- 11.3.4.4. Recent developments,
- 11.3.4.5. strategies,
- 11.3.4.6. financials (based on availability)
- 11.3.5. CENTOGENE N.V.
- 11.3.5.1. Overview,
- 11.3.5.2. Products & services,
- 11.3.5.3. SWOT analysis,
- 11.3.5.4. Recent developments,
- 11.3.5.5. strategies,
- 11.3.5.6. financials (based on availability)
- 11.3.6. Axon Medchem
- 11.3.6.1. Overview,
- 11.3.6.2. Products & services,
- 11.3.6.3. SWOT analysis,
- 11.3.6.4. Recent developments,
- 11.3.6.5. strategies,
- 11.3.6.6. financials (based on availability)
- 11.3.7. Sino Biological Inc.
- 11.3.7.1. Overview,
- 11.3.7.2. Products & services,
- 11.3.7.3. SWOT analysis,
- 11.3.7.4. Recent developments,
- 11.3.7.5. strategies,
- 11.3.7.6. financials (based on availability)
- 11.3.8. R&D System
- 11.3.8.1. Overview,
- 11.3.8.2. Products & services,
- 11.3.8.3. SWOT analysis,
- 11.3.8.4. Recent developments,
- 11.3.8.5. strategies,
- 11.3.8.6. financials (based on availability)
- 11.3.9. BioVision Inc.
- 11.3.9.1. Overview,
- 11.3.9.2. Products & services,
- 11.3.9.3. SWOT analysis,
- 11.3.9.4. Recent developments,
- 11.3.9.5. strategies,
- 11.3.9.6. financials (based on availability)
- 11.3.10. Myriad RBM
- 11.3.10.1. Overview,
- 11.3.10.2. Products & services,
- 11.3.10.3. SWOT analysis,
- 11.3.10.4. Recent developments,
- 11.3.10.5. strategies,
- 11.3.10.6. financials (based on availability)
- 11.3.11. Other Prominent Players
- 11.3.11.1. Overview,
- 11.3.11.2. Products & services,
- 11.3.11.3. SWOT analysis,
- 11.3.11.4. Recent developments,
- 11.3.11.5. strategies,
- 11.3.11.6. financials (based on availability)
- 11.3.1. F. Hoffmann-La Roche Ltd.
12. Strategic Recommendation
Product Code: FBI102173
List of Tables
- Table 1: Global Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2021-2034
- Table 2: Global Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 3: Global Biomarkers Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
- Table 4: North America Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2021-2034
- Table 5: North America Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 6: North America Biomarkers Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
- Table 7: Europe Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2021-2034
- Table 8: Europe Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 9: Europe Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 10: Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2021-2034
- Table 11: Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 12: Asia Pacific Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Latin America Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2021-2034
- Table 14: Latin America Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 15: Latin America Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 16: Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, by Indication, 2021-2034
- Table 17: Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2021-2034
- Table 18: Middle East & Africa Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Biomarkers Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
- Figure 2: Global Biomarkers Market Value Share (%), by Indication 2025 & 2034
- Figure 3: Global Biomarkers Market Forecast (US$ Mn), by Oncology, 2021-2034
- Figure 4: Global Biomarkers Market Forecast (US$ Mn), by Cardiology, 2021-2034
- Figure 5: Global Biomarkers Market Forecast (US$ Mn), by Neurology, 2021-2034
- Figure 6: Global Biomarkers Market Forecast (US$ Mn), by Others, 2021-2034
- Figure 7: Global Biomarkers Market Value Share (%), by End User, 2025 & 2034
- Figure 8: Global Biomarkers Market Forecast (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2021-2034
- Figure 9: Global Biomarkers Market Forecast (US$ Mn), by Diagnostics and Research Laboratories, 2021-2034
- Figure 10: Global Biomarkers Market Forecast (US$ Mn), by Hospitals and Specialty Clinics, 2021-2034
- Figure 11: Global Biomarkers Market Forecast (US$ Mn), by Others, 2021-2034
- Figure 12: Global Biomarkers Market Value (US$ Mn), by Region, 2025 & 2034
- Figure 13: North America Biomarkers Market Value (US$ Mn), by Indication, 2025 & 2034
- Figure 14: North America Biomarkers Market Value Share (%), by Indication, 2025
- Figure 15: North America Biomarkers Market Value (US$ Mn), by End User, 2025 & 2034
- Figure 16: North America Biomarkers Market Value Share (%), by End User, 2025
- Figure 17: North America Biomarkers Market Value (US$ Mn), By Country, 2025 & 2034
- Figure 18: North America Biomarkers Market Value Share (%), By Country, 2025
- Figure 19: Europe Biomarkers Market Value (US$ Mn), by Indication, 2025 & 2034
- Figure 20: Europe Biomarkers Market Value Share (%), by Indication, 2025
- Figure 21: Europe Biomarkers Market Value (US$ Mn), by End User, 2025 & 2034
- Figure 22: Europe Biomarkers Market Value Share (%), by End User, 2025
- Figure 23: Europe Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 24: Europe Biomarkers Market Value Share (%), By Country/ Sub-region, 2025
- Figure 25: Asia Pacific Biomarkers Market Value (US$ Mn), by Indication, 2025 & 2034
- Figure 26: Asia Pacific Biomarkers Market Value Share (%), by Indication, 2025
- Figure 27: Asia Pacific Biomarkers Market Value (US$ Mn), by End User, 2025 & 2034
- Figure 28: Asia Pacific Biomarkers Market Value Share (%), by End User, 2025
- Figure 29: Asia Pacific Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 30: Asia Pacific Biomarkers Market Value Share (%), By Country/ Sub-region, 2025
- Figure 31: Latin America Biomarkers Market Value (US$ Mn), by Indication, 2025 & 2034
- Figure 32: Latin America Biomarkers Market Value Share (%), by Indication, 2025
- Figure 33: Latin America Biomarkers Market Value (US$ Mn), by End User, 2025 & 2034
- Figure 34: Latin America Biomarkers Market Value Share (%), by End User, 2025
- Figure 35: Latin America Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 36: Latin America Biomarkers Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Middle East & Africa Biomarkers Market Value (US$ Mn), by Indication, 2025 & 2034
- Figure 38: Middle East & Africa Biomarkers Market Value Share (%), by Indication, 2025
- Figure 39: Middle East & Africa Biomarkers Market Value (US$ Mn), by End User, 2025 & 2034
- Figure 40: Middle East & Africa Biomarkers Market Value Share (%), by End User, 2025
- Figure 41: Middle East & Africa Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 42: Middle East & Africa Biomarkers Market Value Share (%), By Country/ Sub-region, 2025
- Figure 43: Global Biomarkers Market Share (%), By Company, 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.